Shasha Li Selected Research

Liver Neoplasms (Liver Cancer)

1/2022	CPI-203 improves the efficacy of anti-PD-1 therapy by inhibiting the induced PD-L1 overexpression in liver cancer.
6/2021	Improved delivery system for celastrol-loaded magnetic Fe3O4/α-Fe2O3 heterogeneous nanorods: HIF-1α-related apoptotic effects on SMMC-7721 cell.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shasha Li Research Topics

Disease

41	Neoplasms (Cancer) 03/2022 - 01/2012
15	Infections 06/2022 - 10/2012
9	COVID-19 10/2022 - 09/2020
8	Stroke (Strokes) 09/2022 - 02/2017
7	Inflammation (Inflammations) 01/2022 - 01/2015
7	Hypoxia (Hypoxemia) 01/2022 - 09/2011
6	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2017
5	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2015
4	Virus Diseases (Viral Diseases) 01/2022 - 05/2020
4	Breast Neoplasms (Breast Cancer) 12/2021 - 02/2015
4	Carcinogenesis 01/2020 - 02/2011
4	Pancreatic Neoplasms (Pancreatic Cancer) 05/2015 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2020
3	Pneumonia (Pneumonitis) 10/2021 - 01/2021
3	Communicable Diseases (Infectious Diseases) 01/2021 - 12/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2017
3	Adenocarcinoma 01/2020 - 01/2012
3	Nasopharyngeal Carcinoma 01/2019 - 08/2016
3	Osteoarthritis 05/2014 - 12/2011
2	Echinococcosis (Hydatid Cysts) 07/2022 - 07/2021
2	Glioma (Gliomas) 01/2022 - 06/2018
2	Sepsis (Septicemia) 01/2022 - 12/2021
2	Obesity 01/2022 - 06/2020
2	Liver Neoplasms (Liver Cancer) 01/2022 - 06/2021
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2020
2	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 05/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2021 - 05/2014
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 05/2014
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 06/2017
2	Sarcoma (Soft Tissue Sarcoma) 06/2017 - 01/2012
2	Human Influenza (Influenza) 11/2013 - 10/2012
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2011 - 10/2010
1	Cysts 07/2022
1	Sheep Diseases (Sheep Disease) 05/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
11	Biomarkers (Surrogate Marker)IBA 07/2021 - 04/2011
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2018
5	AntigensIBA 07/2022 - 05/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
5	CytokinesIBA 01/2021 - 11/2013
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 12/2014
4	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2015
4	Therapeutic UsesIBA 01/2022 - 01/2013
4	InterferonsIBA 01/2021 - 05/2020
4	Biological ProductsIBA 11/2018 - 11/2013
4	Messenger RNA (mRNA)IBA 10/2012 - 01/2009
3	Antiviral Agents (Antivirals)IBA 06/2022 - 01/2021
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 10/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2013
3	Capsules (Microcapsules)IBA 01/2022 - 09/2020
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2011
3	NaphthalimidesIBA 10/2017 - 06/2014
3	LuciferasesIBA 01/2015 - 01/2012
2	Immunoglobulin G (IgG)IBA 07/2022 - 06/2020
2	AntibodiesIBA 07/2022 - 07/2021
2	VaccinesIBA 06/2022 - 05/2022
2	HydrogelsIBA 03/2022 - 01/2022
2	Gemcitabine FDA Link 03/2022 - 10/2018
2	Peptides (Polypeptides)IBA 03/2022 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 03/2022 - 10/2019
2	CreatinineIBA 01/2022 - 12/2021
2	LDL Receptors (LDL Receptor)IBA 01/2022 - 11/2016
2	ChromatinIBA 01/2022 - 01/2012
2	CholesterolIBA 01/2022 - 01/2016
2	EnzymesIBA 01/2022 - 02/2015
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 12/2021
2	NitrogenIBA 01/2022 - 12/2021
2	Sirtuin 1IBA 01/2022 - 12/2021
2	GoldIBA 01/2022 - 11/2016
2	BilirubinIBA 01/2022 - 01/2021
2	doxorubicin-DNAIBA 01/2022 - 11/2016
2	Malondialdehyde (Propanedial)IBA 12/2021 - 10/2021
2	Glutathione PeroxidaseIBA 12/2021 - 10/2021
2	teleocalcinIBA 12/2021 - 12/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 10/2021
2	Superoxide DismutaseIBA 12/2021 - 10/2021
2	Long Noncoding RNAIBA 01/2021 - 04/2020
2	Viral ProteinsIBA 01/2021 - 01/2017
2	Interferon Type IIBA 01/2021 - 01/2021
2	Alanine Transaminase (SGPT)IBA 12/2020 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 06/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2020 - 01/2019
2	Monophenol Monooxygenase (Tyrosinase)IBA 09/2019 - 10/2011
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 08/2014
2	Topoisomerase InhibitorsIBA 10/2017 - 06/2017
2	LSS-11IBA 10/2017 - 06/2017
2	MicroRNAs (MicroRNA)IBA 02/2015 - 05/2014
2	WP1066IBA 05/2014 - 05/2014
2	OxidesIBA 11/2013 - 01/2012
1	Cytidine Triphosphate (CTP)IBA 09/2022

Therapy/Procedure

26	Therapeutics 10/2022 - 02/2011
10	Immunotherapy 01/2022 - 01/2021
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2021 - 10/2010
5	Drug Therapy (Chemotherapy) 09/2021 - 01/2012
3	Aftercare (After-Treatment) 06/2021 - 05/2014
2	Transplantation 01/2022 - 12/2021
2	Critical Care (Surgical Intensive Care) 01/2022 - 12/2021